MULTI-OMICS ANALYSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH ANTI-PD-L1 PLUS ANTI-CTLA-4 AND LOCOREGIONAL THERAPY: CORRELATIVE STUDY OF PHASE2 TRIAL

被引：0
|
作者：
Myojin, Yuta [1 ]
Babei, Sepideh [2 ]
Hoffman, Christoph [2 ]
Kedei, Noemi [1 ]
Ruf, Benjamin [1 ]
Benmebarek, Mohamed-Reda [1 ]
Bauer, Kylynda [1 ]
Huang, Patrick [1 ]
Trehan, Rajiv [1 ]
Ma, Chi [1 ]
Monge, Cecilia [1 ]
Xie, Changqing [1 ]
Armstrong, Paul [3 ]
Duffy, Austin [3 ]
Korangy, Firouzeh [1 ]
Claassen, Manfred [2 ]
Greten, Tim [1 ]
机构：
[1] Natl Canc Inst, Bethesda, MD USA
[2] Univ Tubingen, Tubingen, Germany
[3] Mater Misericordiae Univ Hosp, Dublin, Ireland
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1815
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Synergistic efficacy of anti-PD-L1/IL-15 fusion protein in combination with anti-CTLA-4 antibody in a murine orthotopic 4T1 breast carcinoma model
    Martomo, Stella
    Lu, Dan
    Patel, Jeegar
    Polonskaya, Zhanna
    Luna, Xenia
    McCracken, Kevin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [22] Abscopal Effect in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors (Anti-CTLA-4 and Anti-PD1): A Retrospective Analysis of a Single Institution
    Carvalho, R. F.
    Ferrigno, R.
    Marotta, R. C.
    Amarantes, M. P. F.
    Schmerling, R. A.
    Haddad, C. K.
    Gil, E.
    Moraes, P. L.
    Zanuncio, P. H.
    Buzaid, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S159 - S159
  • [23] Real-world efficacy and safety data of anti-PD-1 plus anti-CTLA-4 combination therapy in Chinese patients with advanced melanoma.
    Wen, Xizhi
    Zhang, Xiaoshi
    Ding, Ya
    Li, Dandan
    Li, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] First-line anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy in Japanese mucosal melanoma: A retrospective, multicenter study (JMAC study)
    Nakamura, Y.
    Namikawa, K.
    Yoshikawa, S.
    Kiniwa, Y.
    Maekawa, T.
    Yamasaki, O.
    Isei, T.
    Matsushita, S.
    Nomura, M.
    Nakai, Y.
    Fukushima, S.
    Saito, S.
    Takenouchi, T.
    Tanaka, R.
    Kato, H.
    Otsuka, A.
    Matsuya, T.
    Baba, N.
    Nagase, K.
    Inozume, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S876 - S876
  • [25] Intratumoral CD16± Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
    Lee, Hansol
    Ferguson, Angela L.
    Quek, Camelia
    Vergara, Ismael A.
    daSilva, Ines Pires
    Allen, Ruth
    Gide, Tuba Nur
    Conway, Jordan W.
    Koufariotis, Lambros T.
    Hayward, Nicholas K.
    Waddell, Nicola
    Carlino, Matteo S.
    Menzies, Alexander M.
    Saw, Robyn P. M.
    Shklovskaya, Elena
    Rizos, Helen
    Lo, Serigne
    Scolyer, Richard A.
    V. Long, Georgina
    Palendira, Umaimaintha
    Wilmott, James S.
    CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2513 - 2524
  • [26] S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
    Wagner, Nikolaus B.
    Forschner, Andrea
    Leiter, Ulrike
    Garbe, Claus
    Eigentler, Thomas K.
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 339 - 346
  • [27] S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
    Nikolaus B Wagner
    Andrea Forschner
    Ulrike Leiter
    Claus Garbe
    Thomas K Eigentler
    British Journal of Cancer, 2018, 119 : 339 - 346
  • [28] Combination of the EP and Anti-PD-1 Pathway or Anti-CTLA-4 for the Phase III Trial of Small-Cell Lung Cancer: A Meta-Analysis
    Abunasser, Abdulhakim A. A.
    Xue, Jinmin
    Balawi, Ehab J. A.
    Zhu, Yuxi
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [29] A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
    Patel, Sandip P.
    Othus, Megan
    Chae, Young Kwang
    Giles, Francis J.
    Hansel, Donna E.
    Singh, Preet Paul
    Fontaine, Annette
    Shah, Manisha
    Kasi, Anup
    Al Baghdadi, Tareq
    Matrana, Marc
    Gatalica, Zoran
    Korn, W. Michael
    Hayward, Jourdain
    McLeod, Christine
    Chen, Helen X.
    Sharon, Elad
    Mayerson, Edward
    Ryan, Christopher W.
    Plets, Melissa
    Blanke, Charles
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2020, 26 (10) : 2290 - 2296
  • [30] Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study
    Umeda, Yoshiyasu
    Yoshikawa, Shusuke
    Kiniwa, Yukiko
    Maekawa, Takeo
    Yamasaki, Osamu
    Isei, Taiki
    Matsushita, Shigeto
    Nomura, Motoo
    Nakai, Yasuo
    Fukushima, Satoshi
    Saito, Shintaro
    Takenouchi, Tatsuya
    Tanaka, Ryo
    Kato, Hiroshi
    Otsuka, Atsushi
    Matsuya, Taisuke
    Baba, Natsuki
    Nagase, Kotaro
    Inozume, Takashi
    Onuma, Takehiro
    Kuwatsuka, Yutaka
    Fujimoto, Noriki
    Kaneko, Takahide
    Onishi, Masazumi
    Namikawa, Kenjiro
    Yamazaki, Naoya
    Nakamura, Yasuhiro
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 361 - 372
12345